AGLE - Aeglea Biotherapeutics prices $60M equity offering February, 06 2019 05:20 AM Aeglea BioTherapeutics Inc. Aeglea BioTherapeutics (NASDAQ:AGLE) has priced public offering of 3.75M common stock at $8.00 per share, for expected gross proceeds of ~$60M. More news on: Aeglea BioTherapeutics, Healthcare stocks news, Read more ...